ERBB2 and breast cancer: If confirmed in independent studies, it suggests that the cut-off to consider high-risk patients after NAC completion should be different according to BC subtypes: 4 or more nodes involved for luminal BC patients, and 1 for TNBC and HER-2 positive BC patients.